Analytical Validation of an Automated Point‐of‐Care Immunoassay for the Measurement of Feline Pancreatic Lipase Immunoreactivity Concentration (Vcheck fPL 2.0)
Veterinary Clinical Pathology · 2025
DOI: 10.1111/vcp.70018 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Veterinary Clinical Pathology, 2025. Verfasst von Lisa Wetzel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Lipase, Point-of-Care Systems, Cat Diseases, Pancreatitis. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Michigan State University, Texas A&M University Gastrointestinal Laboratory.
Abstract (Originalsprache)
Background
Pancreatic lipase assays are commonly utilized in the diagnostic approach to suspected pancreatitis in cats. The Vcheck fPL 2.0 assay is commercially available; however, analytical validation has yet to be reported in the peer‐reviewed literature.
Objective
To evaluate the analytic validity of a fluorescent immunoassay for the point‐of‐care quantification of feline pancreatic lipase immunoreactivity (Vcheck fPL 2.0 assay).
Methods
Linearity was assessed via dilutional parallelism. Intra‐ and interassay variability was assessed by calculating coefficients of variation (%CV) across replicates on the same day and across multiple days, respectively. Bilirubin, hemoglobin, and intralipid (intralipid 30% IV emulsion, VWR, Radnor, PA, USA) were utilized to evaluate the potential effects of interfering substances on the assay.
Results
Linearity was sub‐optimal, with 12/15 diluted runs having an O/E ratio outside of the 80–120% target range. The mean %CV was 10.2% for intra‐assay variability and 16.3% for interassay variability. Interfering substances had no significant effect on the results of the Vcheck fPL 2.0 assay ( P = 0.888).
Conclusions
The Vcheck fPL 2.0 appears to have poor linearity and suboptimal precision, limiting the accurate interpretation of results. Additional assay optimization should be considered prior to routine clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.
- Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
ORCID-Profile: Harry Cridge
Förderung
- Michigan State University
- Texas A&M University Gastrointestinal Laboratory
Zitieren
APA
Wetzel, L., Steiner, J. M., & Cridge, H. (2025). Analytical Validation of an Automated Point‐of‐Care Immunoassay for the Measurement of Feline Pancreatic Lipase Immunoreactivity Concentration (Vcheck fPL 2.0). Veterinary Clinical Pathology. https://doi.org/10.1111/vcp.70018
Vancouver
Wetzel L, Steiner JM, Cridge H. Analytical Validation of an Automated Point‐of‐Care Immunoassay for the Measurement of Feline Pancreatic Lipase Immunoreactivity Concentration (Vcheck fPL 2.0). Veterinary Clinical Pathology. 2025. doi:10.1111/vcp.70018
BibTeX
@article{Wetzel2025,
author = {Wetzel, Lisa and Steiner, Joerg M and Cridge, Harry},
title = {Analytical Validation of an Automated Point‐of‐Care Immunoassay for the Measurement of Feline Pancreatic Lipase Immunoreactivity Concentration (Vcheck fPL 2.0)},
journal = {Veterinary Clinical Pathology},
year = {2025},
doi = {10.1111/vcp.70018}
}
EUVIMED